The U.S. pharmaceutical industry heavily profits from taxpayer-funded research while delivering subpar healthcare outcomes. Companies often manipulate patent laws to stifle competition, as seen with Purdue Pharma's introduction of an addictive opioid, despite knowing its dangers. This highlights a troubling relationship between pharmaceutical firms and regulatory agencies, raising serious ethical concerns.
